Japan Drug Testing Market Size & Outlook, 2025-2030
The drug testing market in Japan is expected to reach a projected revenue of US$ 279.8 million by 2030. A compound annual growth rate of 5.6% is expected of Japan drug testing market from 2025 to 2030.
Quest Diagnostics Inc, Abbott Laboratories, QuidelOrtho Corp, Roche Holding AG ADR, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Labcorp Holdings Inc, Clinical Reference Laboratory, Cordant Health Solutions, Legacy Medical, Draegerwerk AG & Co KGaA, Omega Laboratories
Other key industry trends
In terms of revenue, Japan accounted for 1.5% of the global drug testing market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Asia Pacific, China drug testing market is projected to lead the regional market in terms of revenue in 2030.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 653.1 million by 2030.
Japan has very strict drug laws and one of the lowest numbers of drug users in the world. The lifetime usage of illicit drugs in Japan is much lower than in several other countries. However, in the recent past, drug use in Japan has increased.
To control the consumption of illicit drugs, the government is focusing on formulating preventive policies. For instance, in 2021, the Japan Ministry of Health announced a ban on cannabis consumption and possession.
Along with market players in Japan, the government is making collaborative efforts to boost drug testing in the region. In October 2023, the Japanese government dispensed drug testing kits to the Maldives Customs Service and Maldives National Defense Force (MNDF).
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Drug Testing Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 36.37% in 2024.
Horizon Databook has segmented the Japan drug testing market based on consumables, instruments, rapid testing devices, services covering the revenue growth of each sub-segment from 2018 to 2030.
Japan has very strict drug laws and one of the lowest numbers of drug users in the world. The lifetime usage of illicit drugs in Japan is much lower than in several other countries. However, in the recent past, drug use in Japan has increased.
To control the consumption of illicit drugs, the government is focusing on formulating preventive policies. For instance, in 2021, the Japan Ministry of Health announced a ban on cannabis consumption and possession.
Along with market players in Japan, the government is making collaborative efforts to boost drug testing in the region. In October 2023, the Japanese government dispensed drug testing kits to the Maldives Customs Service and Maldives National Defense Force (MNDF).
Japan Drug Testing Market Product Outlook (Revenue, USD Million , 2018-2030)
Consumables
Instruments
Rapid Testing Devices
Services
Japan Drug Testing Market Sample Type Outlook (Revenue, USD Million , 2018-2030)
Urine Samples
Oral Fluid Samples
Hair Samples
Other Samples
Japan Drug Testing Market Drug Type Outlook (Revenue, USD Million , 2018-2030)
Alcohol
Cannabis/Marijuana
Cocaine
Opioids
Amphetamine & Methamphetamine
LSD
Others
Japan Drug Testing Market End Use Outlook (Revenue, USD Million , 2018-2030)
Drug Testing Laboratories
Workplaces
Hospitals
Other
Reasons to subscribe to Drug Testing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Drug Testing Market Outlook databook
Our clientele includes a mix of Drug Testing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan Drug Testing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Drug Testing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.